Chromatin - A new, old drug target?

Chemical Biology and Drug Design

Volumn 72, Issue 3, 2008, Pages 165-170

  Davey, Gabriela E ^a   Davey, Curt A ^a  

^a NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

Author keywords

Cancer; Chromatin; Drug target; Nucleosome; Platinum drug

Indexed keywords

4 [5 (4 METHYL 1 PIPERAZINYL)[2,5' BI 1H BENZIMIDAZOL] 2' YL]PHENOL; AFLATOXIN B1; ALKANE DERIVATIVE; CARBOPLATIN; CHLORMETHINE DERIVATIVE; CHROMOMYCIN A3; CISPLATIN; CISPLATIN DERIVATIVE; CONGOCIDINE; DACTINOMYCIN; DAUNORUBICIN; DIHYDROXYBENZO[A]PYRENE OXIDE; DIMINAZENE ACETURATE; DISTAMYCIN A; DNA BINDING PROTEIN; DUOCARMYCIN SA; ECHINOMYCIN; ETHIDIUM BROMIDE; MITHRAMYCIN; MITOMYCIN; NAKED DNA; NOGALAMYCIN; OXALIPLATIN; PLATINUM DERIVATIVE; PSORALEN; UNCLASSIFIED DRUG; YATAKEMYCIN;

CANCER CELL; CHROMATIN; CHROMATIN STRUCTURE; CYTOTOXICITY; DNA PACKAGING; DRUG DESIGN; DRUG DNA BINDING; DRUG EFFICACY; DRUG MECHANISM; DRUG TARGETING; EXCISION REPAIR; NUCLEOSOME; PRIORITY JOURNAL; REVIEW;

ANTINEOPLASTIC AGENTS; CHROMATIN; CISPLATIN; DNA DAMAGE; DNA REPAIR; HISTONES; HUMANS; NUCLEOSOMES; PLATINUM; TRANSCRIPTION, GENETIC;

EID: 50449106608     PISSN: 17470277     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1747-0285.2008.00697.x     Document Type: Review

References (70)

1. Kornberg R.D., Lorch Y. (2007) Chromatin rules. Nat Struct Mol Biol 14:986 988.
2. Luger K., Mäder A.W., Richmond R.K., Sargent D.F., Richmond T.J. (1997) Crystal structure of the nucleosome core particle at 2.8 Å resolution. Nature 389:251 260.
3. Yuan G.C., Liu Y.J., Dion M.F., Slack M.D., Wu L.F., Altschuler S.J., Rando O.J. (2005) Genome-scale identification of nucleosome positions in S. cerevisiae. Science 309:626 630.
4. Segal E., Fondufe-Mittendorf Y., Chen L., Thåström A., Field Y., Moore I.K., Wang J.P., Widom J. (2006) A genomic code for nucleosome positioning. Nature 442:772 778.
5. Albert I., Mavrich T.N., Tomsho L.P., Qi J., Zanton S.J., Schuster S.C., Pugh B.F. (2007) Translational and rotational settings of H2A.Z nucleosomes across the Saccharomyces cerevisiae genome. Nature 446:572 576.
6. Lee W., Tillo D., Bray N., Morse R.H., Davis R.W., Hughes T.R., Nislow C. (2007) A high-resolution atlas of nucleosome occupancy in yeast. Nat Genet 39:1235 1244.
7. Saha A., Wittmeyer J., Cairns B.R. (2006) Chromatin remodelling: the industrial revolution of DNA around histones. Nat Rev Mol Cell Biol 7:437 447.
8. Cairns B.R. (2007) Chromatin remodeling: insights and intrigue from single-molecule studies. Nat Struct Mol Biol 14:989 996.
9. Boyle A.P., Davis S., Shulha H.P., Meltzer P., Margulies E.H., Weng Z., Furey T.S., Crawford G.E. (2008) High-resolution mapping and characterization of open chromatin across the genome. Cell 132:311 322.
10. Schones D.E., Cui K., Cuddapah S., Roh T.Y., Barski A., Wang Z., Wei G., Zhao K. (2008) Dynamic regulation of nucleosome positioning in the human genome. Cell 132:887 898.
11. Jones P.A., Baylin S.B. (2007) The epigenomics of cancer. Cell 128:683 692.
12. Esteller M. (2007) Cancer epigenomics: DNA methylomes and histone-modification maps. Nat Rev Genet 8:286 298.
13. Weir B.A., Woo M.S., Getz G., Perner S., Ding L., Beroukhim R., Lin W.M., Weir B.A., Woo M.S., Getz G., Perner S., Ding L., Beroukhim R., Lin W.M. et al. (2007) Characterizing the cancer genome in lung adenocarcinoma. Nature 450:893 898.
14. Degenhardt Y.Y., Wooster R., McCombie R.W., Lucito R., Powers S. (2008) High-content analysis of cancer genome DNA alterations. Curr Opin Gen Dev 18:68 72.
15. Richmond T.J., Davey C.A. (2003) The structure of DNA in the nucleosome core. Nature 423:145 150.
16. Davey C.A., Richmond T.J. (2002) DNA-dependent divalent cation binding in the nucleosome core particle. Proc Natl Acad Sci USA 99:11169 11174.
17. Ong M.S., Richmond T.J., Davey C.A. (2007) DNA stretching and extreme kinking in the nucleosome core. J Mol Biol 368:1067 1074.
18. Gottesfeld J.M., Melander C., Suto R.K., Raviol H., Luger K., Dervan P.B. (2001) Sequence-specific recognition of DNA in the nucleosome by pyrrole-imidazole polyamides. J Mol Biol 309:615 629.
19. Suto R.K., Edayathumangalam R.S., White C.L., Melander C., Gottesfeld J.M., Dervan P.B., Luger K. (2003) Crystal structures of nucleosome core particles in complex with minor groove DNA-binding ligands. J Mol Biol 326:371 380.
20. Trzupek J.D., Gottesfeld J.M., Boger D.L. (2006) Alkylation of duplex DNA in nucleosome core particles by duocarmycin SA and yatakemycin. Nat Chem Biol 2:79 82.
21. Subramanian V., Ducept P., Williams R.M., Luger K. (2007) Effects of photochemically activated alkylating agents of the FR900482 family on chromatin. Chem Biol 14:553 563.
22. Millard J.T., Spencer R.J., Hopkins P.B. (1998) Effect of nucleosome structure on DNA interstrand cross-linking reactions. Biochemistry 37:5211 5219.
23. Edayathumangalam R.S., Weyermann P., Gottesfeld J.M., Dervan P.B., Luger K. (2004) Molecular recognition of the nucleosomal "supergroove". Proc Natl Acad Sci USA 101:6864 6869.
24. Lin J.C., Jeong S., Liang G., Takai D., Fatemi M., Tsai Y.C., Egger G., Gal-Yam E.N., Jones P.A. (2007) Role of nucleosomal occupancy in the epigenetic silencing of the MLH1 CpG island. Cancer Cell 12:432 444.
25. Silva J.M., Marran K., Parker J.S., Silva J., Golding M., Schlabach M.R., Elledge S.J., Hannon G.J., Chang K. (2008) Profiling essential genes in human mammary cells by multiplex RNAi screening. Science 319:617 620.
26. Schlabach M.R., Luo J., Solimini N.L., Hu G., Xu Q., Li M.Z., Zhao Z., Schlabach M.R., Luo J., Solimini N.L., Hu G., Xu Q., Li M.Z., Zhao Z. et al. (2008) Cancer proliferation gene discovery through functional genomics. Science 319:620 624.
27. Jamieson E.R., Lippard S.J. (1999) Structure, recognition, and processing of cisplatin-DNA adducts. Chem Rev 99:2467 2498.
28. Barnes K.R., Lippard S.J. (2004) Cisplatin and related anticancer drugs: recent advances and insights. Met Ions Biol Syst 42:143 177.
29. Wang D., Lippard S.J. (2005) Cellular processing of platinum anticancer drugs. Nat Rev Drug Discov 4:307 320.
30. Jung Y., Lippard S.J. (2007) Direct cellular responses to platinum-induced DNA damage. Chem Rev 107:1387 1407.
31. Rabik C.A., Dolan M.E. (2007) Molecular mechanisms of resistance and toxicity associated with platinating agents. Cancer Treat Rev 33:9 23.
32. Kelland L. (2007) The resurgence of platinum-based cancer chemotherapy. Nat Rev Cancer 7:573 584.
33. Galea A.M., Murray V. (2002) The interaction of cisplatin and analogues with DNA in reconstituted chromatin. Biochim Biophys Acta 1579:142 152.
34. Wang D., Hara R., Singh G., Sancar A., Lippard S.J. (2003) Nucleotide excision repair from site-specifically platinum-modified nucleosomes. Biochemistry 42:6747 6753.
35. Polach K.J., Widom J. (1995) Mechanism of protein access to specific DNA sequences in chromatin: a dynamic equilibrium model for gene regulation. J Mol Biol 254:130 149.
36. Anderson J.D., Widom J. (2000) Sequence and position-dependence of the equilibrium accessibility of nucleosomal DNA target sites. J Mol Biol 296:979 987.
37. Davey C.A., Sargent D.F., Luger K., Maeder A.W., Richmond T.J. (2002) Solvent mediated interactions in the structure of the nucleosome core particle at 1.9 Å resolution. J Mol Biol 319:1097 1113.
38. Li G., Levitus M., Bustamante C., Widom J. (2005) Rapid spontaneous accessibility of nucleosomal DNA. Nat Struct Mol Biol 12:46 53.
39. Thoma F. (2005) Repair of UV lesions in nucleosomes - intrinsic properties and remodeling. DNA Repair (Amst) 4:855 869.
40. Beard B.C., Wilson S.H., Smerdon M.J. (2003) Suppressed catalytic activity of base excision repair enzymes on rotationally positioned uracil in nucleosomes. Proc Natl Acad Sci USA 100:7465 7470.
41. Svedruzic Z.M., Wang C., Kosmoski J.V., Smerdon M.J. (2005) Accommodation and repair of a UV photoproduct in DNA at different rotational settings on the nucleosome surface. J Biol Chem 280:40051 40057.
42. Danford A.J., Wang D., Wang Q., Tullius T.D., Lippard S.J. (2005) Platinum anticancer drug damage enforces a particular rotational setting of DNA in nucleosomes. Proc Natl Acad Sci USA 102:12311 12316.
43. Wu B., Dröge P., Davey C.A. (2008) Site selectivity of platinum anticancer therapeutics. Nat Chem Biol 4:110 112.
44. Wheate N.J., Brodie C.R., Collins J.G., Kemp S., Aldrich-Wright J.R. (2007) DNA intercalators in cancer therapy: organic and inorganic drugs and their spectroscopic tools of analysis. Mini Rev Med Chem 7:627 648.
45. Nelson S.M., Ferguson L.R., Denny W.A. (2007) Non-covalent ligand/DNA interactions: minor groove binding agents. Mutat Res 623:24 40.
46. Rajski S.R., Williams R.M. (1998) DNA cross-linking agents as antitumor drugs. Chem Rev 98:2723 2796.
47. Pindur U., Jansen M., Lemster T. (2005) Advances in DNA-ligands with groove binding, intercalating and/or alkylating activity: chemistry, DNA-binding and biology. Curr Med Chem 12:2805 2847.
48. Jakupec M.A., Galanski M., Arion V.B., Hartinger C.G., Keppler B.K. (2008) Antitumour metal compounds: more than theme and variations. Dalton Trans 2:183 194.
49. Bruijnincx P.C., Sadler P.J. (2008) New trends for metal complexes with anticancer activity. Curr Opin Chem Biol 12:197 206.
50. Portugal J., Waring M.J. (1986) Antibiotics which can alter the rotational orientation of nucleosome core DNA. Nucleic Acids Res 14:8735 8754.
51. Chaires J.B., Dattagupta N., Crothers D.M. (1983) Binding of daunomycin to calf thymus nucleosomes. Biochemistry 22:284 292.
52. Fritzsche H., Wahnert U., Chaires J.B., Dattagupta N., Schlessinger F.B., Crothers D.M. (1987) Anthracycline antibiotics. Interaction with DNA and nucleosomes and inhibition of DNA synthesis. Biochemistry 26:1996 2000.
53. Mir M.A., Das S., Dasgupta D. (2004) N-terminal tail domains of core histones in nucleosome block the access of anticancer drugs, mithramycin and daunomycin, to the nucleosomal DNA. Biophys Chem 109:121 135.
54. Low C.M., Drew H.R., Waring M.J. (1986) Echinomycin and distamycin induce rotation of nucleosome core DNA. Nucleic Acids Res 14:6785 6801.
55. Fox K.R., Cons B.M. (1993) Interaction of mithramycin with DNA fragments complexed with nucleosome core particles: comparison with distamycin and echinomycin. Biochemistry 32:7162 7171.
56. Portugal J., Waring M.J. (1987) Interaction of nucleosome core particles with distamycin and echinomycin: analysis of the effect of DNA sequences. Nucleic Acids Res 15:885 903.
57. Leslie K.D., Fox K.R. (2002) Interaction of Hoechst 33258 and echinomycin with nucleosomal DNA fragments containing isolated ligand binding sites. Biochemistry 41:3484 3497.
58. McMurray C.T., van Holde K.E. (1991) Binding of ethidium to the nucleosome core particle. 1. Binding and dissociation reactions. Biochemistry 30:5631 5643.
59. McMurray C.T., Small E.W., van Holde K.E. (1991) Binding of ethidium to the nucleosome core particle. 2. Internal and external binding modes. Biochemistry 30:5644 5652.
60. Mir M.A., Majee S., Das S., Dasgupta D. (2003) Association of chromatin with anticancer antibiotics, mithramycin and chromomycin A3. Bioorg Med Chem 11:2791 2801.
61. Moyer R., Marien K., van Holde K., Bailey G. (1989) Site-specific aflatoxin B1 adduction of sequence-positioned nucleosome core particles. J Biol Chem 264:12226 12231.
62. Smith B.L., MacLeod M.C. (1993) Covalent binding of the carcinogen benzo[a]pyrene diol epoxide to Xenopus laevis 5 S DNA reconstituted into nucleosomes. J Biol Chem 268:20620 20629.
63. Thrall B.D., Mann D.B., Smerdon M.J., Springer D.L. (1994) Nucleosome structure modulates benzo[a]pyrenediol epoxide adduct formation. Biochemistry 33:2210 2216.
64. Millard J.T., Wilkes E.E. (2001) Diepoxybutane and diepoxyoctane interstrand cross-linking of the 5S DNA nucleosomal core particle. Biochemistry 40:10677 10685.
65. Cera C., Palumbo M., Palu G., Crothers D.M. (1990) N-methylmitomycin A cross-linking to nucleosomal structure. Anticancer Drug Des 5:55 58.
66. Hanson C.V., Shen C.K., Hearst J.E. (1976) Cross-linking of DNA in situ as a probe for chromatin structure. Science 193:62 64.
67. Millard J.T., Wilkes E.E. (2000) cis- and trans- diamminedichloroplatinum(II) interstrand cross-linking of a defined sequence nucleosomal core particle. Biochemistry 39:16046 16055.
68. Takahara P.M., Rosenzweig A.C., Frederick C.A., Lippard S.J. (1995) Crystal structure of double-stranded DNA containing the major adduct of the anticancer drug cisplatin. Nature 377:649 652.
69. Takahara P.M., Frederick C.A., Lippard S.J. (1996) Crystal structure of the anticancer drug cisplatin bound to duplex DNA. J Am Chem Soc 118:12309 12321.
70. Springler B., Whittington D.A., Lippard S.J. (2001) 2.4 Å crystal structure of an oxaliplatin 1,2-d(GpG) intrastrand cross-link in a DNA dodecamer duplex. Inorg Chem 40:5596 5602.